Safety of sodium‐glucose cotransporter 2 inhibitors drugs among heart failure patients: a systematic review and meta‐analysis

Safety of sodium‐glucose cotransporter 2 inhibitors drugs among heart failure patients: a systematic review and meta‐analysis

Abstract Sodium–glucose cotransporter‐2 inhibitors (SGLT2is) reduce morbidity and mortality for heart failure (HF) patients and are recommended as cornerstones for their medical therapy. Utilization in clinical practice remains low for multiple reasons, one of which may be adverse events. We investi...

Full description

Bibliographic Details
Main Authors: Hamidreza Soleimani, Behrad Saeedian, Yeganeh Pasebani, Nastaran Babajani, Amirreza Pashapour Yeganeh, Pegah Bahirai, Hossein Navid, Ahmad Amin, Marc D. Samsky, Micheal G. Nanna, Kaveh Hosseini
Format: Article
Language:English
Published: Wiley 2024-04-01
Series:ESC Heart Failure
Subjects:
SGLT2i
Sodium–glucose cotransporter‐2 inhibitors
Heart failure
Safety outcomes
Meta‐analysis
Systematic review
Online Access:https://doi.org/10.1002/ehf2.14633

Internet

https://doi.org/10.1002/ehf2.14633

Similar Items